BioPlus

Leader in HA filler manufacturing

Contract with CKD expected to boost domestic sales


BioPlus Co., Ltd. and Chong Kun Dang Pharma, one of the biggest pharmaceutical companies in Korea with a capital of 20 million USD, signed an exclusive distributorship contract on February 10, 2017 for the distribution of BioPlus Co., Ltd.'s SkinPLus-HYAL and HyalDew products in the region of Korea . The products are planned to be launched on April.

BioPlus Co., Ltd. products are already recognized as a long lasting product with a high quality standard. Chong Kun Dang Pharma's brand image and their sales ability in conjunction with the quality and standard of BioPlus Co., Ltd., products will create a synergy to boost sales for both companies.